Evolving Market Trends In The Epigenetics Industry: Innovations in DNA Sequencing: Transforming Precision Medicine Through Advanced Technologies

The Epigenetics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Epigenetics Market Size During the Forecast Period?
The market size for epigenetics has seen a rapid increase over the past few years. The market value is expected to elevate from $10.65 billion in 2024 to about $12.83 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 20.4%. The reason for this expansion during the historic period can be linked to higher research funding, growing occurrence of chronic diseases, development of personalized medical treatments, cancer research, and an aging population.

In the coming years, significant expansion is anticipated for the epigenetics market, predicted to reach a value of $29.08 billion in 2029, with a compound annual growth rate of 22.7%. The growth within the projection period can be credited to factors such as the development of epigenetic drugs, the application of epigenetics in environmental health and precision agriculture, as well as regulatory support. Factors like patient awareness and advocacy also contribute to the market's growth. Key trends during the forecast period will likely be epitrancriptomics, single-cell epigenomics, epigenetic editing, epigenetic biomarkers, research on aging and longevity, and interactions between microbiome and epigenome.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7070

What Are the High-Growth Segments in the Epigenetics Market?
The epigenetics market covered in this report is segmented -

1) By Product: Reagents, Enzymes, Instruments, Kits
2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures
3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications
4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:
1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes
2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes
3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers
4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

What Key Drivers Are Expected to Influence Future Epigenetics Market Growth?
The escalating incidence of cancer and other illnesses is significantly propelling the expansion of the epigenetics market. This surge in disease prevalence enhances the need for epigenetics. For instance, the National Cancer Institute (NCI), a US government entity, stated in May 2024 that around 20 million new cancer cases were reported in 2022, leading to roughly 9.7 million disease-associated deaths. Predictions suggest that by 2040, the yearly incidence of fresh cancer cases will surge to 29.9 million, with cancer-associated fatalities totaling 15.3 million. Additionally, the Centers for Disease Control and Prevention (CDC) reports that nearly 659,000 individuals die annually from heart disease in the United States. With the growing incidences of cancer and other ailments, there is an increasing need to conduct tests to understand the genetic changes which will inevitably cause a spike in the usage and requirement for epigenetics. Consequently, the escalating incidences of cancer and other illnesses are propelling the growth of the epigenetics market in the forthcoming years.

Which Companies Hold the Largest Share Across Different Epigenetics Market Segments?
Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

What Trends Are Driving Growth in The Epigenetics Market?
Leading corporations in the epigenetics market are concentrating on the creation of technologically sophisticated solutions, including DNA sequencing techniques, to amplify precision medicine and boost comprehension and outcomes of disease treatment. DNA sequencing methods are procedures used to ascertain the sequence of nucleotides in a DNA molecule, providing in-depth genetic studies. This data is vital for detecting genetic variations associated with a disease and propelling precision medicine. For example, Illumina Inc., an American biotech firm, introduced Illumina Complete Long Read Technology in March 2023. This technology enables both long-read and short-read sequencing on a single tool, thereby significantly adding to the versatility of genomic research. By reducing DNA input needs and simplifying the library preparation process, it makes it possible to work with difficult samples. The technology delivers high precision in variant calling, generating dependable data crucial for thorough genomic analysis.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

What Are the Emerging Geographies for The Epigenetics Market Growth?
North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Epigenetics Market?
2. What is the CAGR expected in the Epigenetics Market?
3. What Are the Key Innovations Transforming the Epigenetics Industry?
4. Which Region Is Leading the Epigenetics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.